GSK launches 4 mobile dental vans in Gurgaon The four vans were flagged off in the presence of senior leaders of the GlaxoSmithKline Asia Private Limited, along with… Updated: November 9, 2022 21:03 IST
GSK’s blood cancer drug fails main trial goal, shares fall As oncology is a key area of focus for GSK as a standalone prescription medicine and vaccine business, the company’s… November 7, 2022 16:04 IST
Delhi HC stays DCGI order cancelling Sensodyne licence for GSK contractor However, the bench asked the company to “ensure that no statements or advertisements which may appear in periodicals or any… March 18, 2022 01:30 IST
US FDA suggests restricted use of GlaxoSmithKline-Vir COVID-19 drug based on variants in circulation The GSK-Vir drug is one of the few COVID-19 treatments shown to have worked against the original Omicron variant leading… February 24, 2022 11:41 IST
Nifty needs to cross 17600 to reclaim 18000 levels; buy these two stocks for over 8% returns Nifty has reached a good hurdle zone of 17600, if it manages to sustain above the said levels than 18000… December 13, 2021 08:58 IST
Analyst Corner: Maintain ‘add’ on GSK Pharma with TP of Rs 1,613 Company has impaired Vemgal by Rs 1.19 billion to reflect the estimated realisable value of Rs 1.8 billion at which… May 22, 2021 05:15 IST
Godrej Consumer Products shares zoom 25% on HUL’s Sudhir Sitapati’s appointment as MD and CEO, Q4 results Godrej Consumer Products share price zoomed 25 per cent to a fresh 52-week high of Rs 894 apiece intraday on… May 12, 2021 11:38 IST
GSK Pharma rating – Add: Sale of plant to improve return ratios Trend of recovery in acute therapies likely to continue; ‘Add’ rating retained with revised TP of Rs 1,575 April 5, 2021 02:30 IST
Analyst Corner – GlaxoSmithKline Pharma: Maintain ‘add’ with revised TP of Rs 1,575 We expect this trend in recovery in the acute therapies to continue in the coming quarters. GSKP’s exposure only to… April 3, 2021 04:15 IST
GSK seeks lead in triple lung drug market with 2016 filing plan The US drug filing will include clinical trials data now in hand from the closed triple combination therapy development programme,… June 2, 2016 14:01 IST
GlaxoSmithKline posts loss as it integrates new businesses Drug makers like GSK have been trying to focus on strengths amid competition from generic drug makers British-based drug maker… February 4, 2016 17:30 IST
Glenmark in agreement with Celon Pharma Glenmark obtains semi-exclusive marketing and distribution rights for the product across 15 European countries, including Great Britain and Germany upon… October 26, 2015 16:54 IST
Novartis acquires all remaining rights to GSK’s Ofatumumab To develop treatments for MS and other autoimmune indications August 21, 2015 14:49 IST
GlaxoSmithKline faces new corruption allegations, this time in Romania Drugmaker GlaxoSmithKline , which was fined a record 3 billion yuan ($483 million) for corruption in China last year and… July 30, 2015 12:55 IST
MSF takes to social media to pressurise GSK, Pfizer to cut price of flu shot Urges public to #AskPharma how developing countries can get ‘A FAIR SHOT’ when vaccine prices are being kept secret Updated: May 5, 2015 11:11 IST
Snapdeal beefs up its top management Sandeep Komaravelly, who spearheaded Snapdeal’s marketing function for five years, has moved to another strategic leadership role within the company. April 29, 2015 02:26 IST
GSK agrees UK deal for meningitis shot after Novartis stand-off Britain will become the first country in the world to have a nationwide vaccination programme for the potentially deadly childhood… Updated: March 30, 2015 11:35 IST
Novartis completes series of transactions with GlaxoSmithKline Acquires certain oncology products and pipeline compounds from GSK Updated: March 23, 2015 10:35 IST
Sun Pharma to buy GSK’s opiates biz in Oz To buy GSK’s opiates business in Australia Updated: March 23, 2015 10:34 IST
Sun Pharma buys GSK Opiates Australia business Pharma major looks to strengthen its portfolio of opiates and access strong capabilities in segment Updated: March 4, 2015 05:15 IST
Sun Pharma to buy GSK’s Opiates business in Australia Drug major Sun Pharma will acquire GlaxoSmithKline’s Opiates business in Australia for an undisclosed amount… March 3, 2015 11:00 IST
Fortune announces list of 2015 ‘World’s Most Admired Companies’ Fortune magazine has announced its list of 2015 ‘World’s Most Admired Companies.’ The companies on the world’s most admired list… February 24, 2015 15:39 IST
